{"entity":{"type":"insider","cik":"0001665299","url":"/insider/0001665299","json_url":"/insider/0001665299.json","name":"Traweek James W JR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":15,"first":"2016-06-01","last":"2019-11-18","span_basis":"filed_date"},"name_variants":[{"name":"Traweek James W JR","source":"filing","n_filings":15,"first_seen":"2016-06-01","last_seen":"2019-11-18"}],"transactions":[{"id":8377141,"accession":"0000905148-19-001003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-19-001003","line_url":"/filing/0000905148-19-001003#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40218.0,"shares_display":"40,218","price_per_share":183.0,"price_display":"183.00","price_state":"stated","total_value":7359894.0,"total_display":"7,359,894.00","total_whole":"7,359,894","shares_owned_after":3063567.0,"shares_owned_after_display":"3,063,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-18","scope":"insider"},{"id":6569620,"accession":"0000905148-18-000922","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000905148-18-000922","line_url":"/filing/0000905148-18-000922#line-5","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1418.0,"shares_display":"1,418","price_per_share":59.8952,"price_display":"59.90","price_state":"stated","total_value":84931.3936,"total_display":"84,931.39","total_whole":"84,931","shares_owned_after":3023349.0,"shares_owned_after_display":"3,023,349","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-12","filed_date":"2018-12-12","scope":"insider"},{"id":6569615,"accession":"0000905148-18-000922","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000905148-18-000922","line_url":"/filing/0000905148-18-000922#line-4","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52809.0,"shares_display":"52,809","price_per_share":60.0719,"price_display":"60.07","price_state":"stated","total_value":3172336.9671,"total_display":"3,172,336.97","total_whole":"3,172,337","shares_owned_after":3021931.0,"shares_owned_after_display":"3,021,931","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-12","scope":"insider"},{"id":6569612,"accession":"0000905148-18-000922","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-18-000922","line_url":"/filing/0000905148-18-000922","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56599.0,"shares_display":"56,599","price_per_share":58.77428468877542,"price_display":"58.77","price_state":"stated","total_value":3326565.7391,"total_display":"3,326,565.74","total_whole":"3,326,566","shares_owned_after":2969122.0,"shares_owned_after_display":"2,969,122","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-12","scope":"insider","n_lines":3},{"id":5330291,"accession":"0001140361-17-047825","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047825","line_url":"/filing/0001140361-17-047825#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17000.0,"shares_display":"17,000","price_per_share":28.4715,"price_display":"28.47","price_state":"stated","total_value":484015.5,"total_display":"484,015.50","total_whole":"484,016","shares_owned_after":2912523.0,"shares_owned_after_display":"2,912,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2017-12-29","scope":"insider"},{"id":4996008,"accession":"0001140361-17-047654","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-17-047654","line_url":"/filing/0001140361-17-047654#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":26.1,"price_display":"26.10","price_state":"stated","total_value":5220.0,"total_display":"5,220.00","total_whole":"5,220","shares_owned_after":2895523.0,"shares_owned_after_display":"2,895,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-28","filed_date":"2017-12-28","scope":"insider"},{"id":4996004,"accession":"0001140361-17-047654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-047654","line_url":"/filing/0001140361-17-047654#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":25.8296,"price_display":"25.83","price_state":"stated","total_value":387444.0,"total_display":"387,444.00","total_whole":"387,444","shares_owned_after":2895323.0,"shares_owned_after_display":"2,895,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-27","filed_date":"2017-12-28","scope":"insider"},{"id":4995999,"accession":"0001140361-17-047654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-047654","line_url":"/filing/0001140361-17-047654#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":26.0605,"price_display":"26.06","price_state":"stated","total_value":312726.0,"total_display":"312,726.00","total_whole":"312,726","shares_owned_after":2880323.0,"shares_owned_after_display":"2,880,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":5237971,"accession":"0000905148-17-000941","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-17-000941","line_url":"/filing/0000905148-17-000941#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78275.0,"shares_display":"78,275","price_per_share":24.6528,"price_display":"24.65","price_state":"stated","total_value":1929697.92,"total_display":"1,929,697.92","total_whole":"1,929,698","shares_owned_after":2868323.0,"shares_owned_after_display":"2,868,323","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-14","filed_date":"2017-12-15","scope":"insider"},{"id":5237969,"accession":"0000905148-17-000941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-17-000941","line_url":"/filing/0000905148-17-000941","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121725.0,"shares_display":"121,725","price_per_share":24.881564386937768,"price_display":"24.88","price_state":"stated","total_value":3028708.425,"total_display":"3,028,708.42","total_whole":"3,028,708","shares_owned_after":2789748.0,"shares_owned_after_display":"2,789,748","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-13","filed_date":"2017-12-15","scope":"insider","n_lines":2},{"id":4809718,"accession":"0000905148-17-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-17-000018","line_url":"/filing/0000905148-17-000018#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9392.0,"shares_display":"9,392","price_per_share":21.7247,"price_display":"21.72","price_state":"stated","total_value":204038.3824,"total_display":"204,038.38","total_whole":"204,038","shares_owned_after":1926034.0,"shares_owned_after_display":"1,926,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-30","filed_date":"2017-01-04","scope":"insider"},{"id":3159112,"accession":"0000905148-16-002141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-002141","line_url":"/filing/0000905148-16-002141#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":164753.0,"shares_display":"164,753","price_per_share":22.9909,"price_display":"22.99","price_state":"stated","total_value":3787819.7477,"total_display":"3,787,819.75","total_whole":"3,787,820","shares_owned_after":1916642.0,"shares_owned_after_display":"1,916,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider"},{"id":3312462,"accession":"0000905148-16-002129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-002129","line_url":"/filing/0000905148-16-002129#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2700.0,"shares_display":"2,700","price_per_share":22.0498,"price_display":"22.05","price_state":"stated","total_value":59534.46,"total_display":"59,534.46","total_whole":"59,534","shares_owned_after":1751889.0,"shares_owned_after_display":"1,751,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-16","scope":"insider"},{"id":3312459,"accession":"0000905148-16-002129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-002129","line_url":"/filing/0000905148-16-002129#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6189.0,"shares_display":"6,189","price_per_share":21.3651,"price_display":"21.37","price_state":"stated","total_value":132228.6039,"total_display":"132,228.60","total_whole":"132,229","shares_owned_after":1749189.0,"shares_owned_after_display":"1,749,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-12-14","filed_date":"2016-12-16","scope":"insider"},{"id":3159090,"accession":"0000905148-16-001851","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-16-001851","line_url":"/filing/0000905148-16-001851#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105562.0,"shares_display":"105,562","price_per_share":17.323,"price_display":"17.32","price_state":"stated","total_value":1828650.526,"total_display":"1,828,650.53","total_whole":"1,828,651","shares_owned_after":1743000.0,"shares_owned_after_display":"1,743,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-18","filed_date":"2016-08-18","scope":"insider"},{"id":3159084,"accession":"0000905148-16-001851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001851","line_url":"/filing/0000905148-16-001851#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":144058.0,"shares_display":"144,058","price_per_share":17.2626,"price_display":"17.26","price_state":"stated","total_value":2486815.6308,"total_display":"2,486,815.63","total_whole":"2,486,816","shares_owned_after":1637438.0,"shares_owned_after_display":"1,637,438","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-17","filed_date":"2016-08-18","scope":"insider"},{"id":3159077,"accession":"0000905148-16-001851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001851","line_url":"/filing/0000905148-16-001851#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58600.0,"shares_display":"58,600","price_per_share":16.2108,"price_display":"16.21","price_state":"stated","total_value":949952.88,"total_display":"949,952.88","total_whole":"949,953","shares_owned_after":1493380.0,"shares_owned_after_display":"1,493,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-18","scope":"insider"},{"id":2056691,"accession":"0000905148-16-001715","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-16-001715","line_url":"/filing/0000905148-16-001715#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":19.7511,"price_display":"19.75","price_state":"stated","total_value":1975110.0,"total_display":"1,975,110.00","total_whole":"1,975,110","shares_owned_after":632780.0,"shares_owned_after_display":"632,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-30","filed_date":"2016-06-30","scope":"insider"},{"id":2056688,"accession":"0000905148-16-001715","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001715","line_url":"/filing/0000905148-16-001715#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63700.0,"shares_display":"63,700","price_per_share":19.8282,"price_display":"19.83","price_state":"stated","total_value":1263056.34,"total_display":"1,263,056.34","total_whole":"1,263,056","shares_owned_after":532780.0,"shares_owned_after_display":"532,780","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-29","filed_date":"2016-06-30","scope":"insider"},{"id":2056683,"accession":"0000905148-16-001715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001715","line_url":"/filing/0000905148-16-001715#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900.0,"shares_display":"900","price_per_share":19.7372,"price_display":"19.74","price_state":"stated","total_value":17763.48,"total_display":"17,763.48","total_whole":"17,763","shares_owned_after":469080.0,"shares_owned_after_display":"469,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-28","filed_date":"2016-06-30","scope":"insider"},{"id":2646689,"accession":"0000905148-16-001703","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905148-16-001703","line_url":"/filing/0000905148-16-001703#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21968.0,"shares_display":"21,968","price_per_share":19.1749,"price_display":"19.17","price_state":"stated","total_value":421234.2032,"total_display":"421,234.20","total_whole":"421,234","shares_owned_after":468180.0,"shares_owned_after_display":"468,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-27","filed_date":"2016-06-28","scope":"insider"},{"id":2646685,"accession":"0000905148-16-001703","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001703","line_url":"/filing/0000905148-16-001703","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51435.0,"shares_display":"51,435","price_per_share":19.292972565373773,"price_display":"19.29","price_state":"stated","total_value":992334.0439,"total_display":"992,334.04","total_whole":"992,334","shares_owned_after":446212.0,"shares_owned_after_display":"446,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-24","filed_date":"2016-06-28","scope":"insider","n_lines":2},{"id":2989194,"accession":"0000905148-16-001668","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-16-001668","line_url":"/filing/0000905148-16-001668#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4220.0,"shares_display":"4,220","price_per_share":17.6209,"price_display":"17.62","price_state":"stated","total_value":74360.198,"total_display":"74,360.20","total_whole":"74,360","shares_owned_after":394777.0,"shares_owned_after_display":"394,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-07","filed_date":"2016-06-08","scope":"insider"},{"id":2989190,"accession":"0000905148-16-001668","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001668","line_url":"/filing/0000905148-16-001668#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":17.5596,"price_display":"17.56","price_state":"stated","total_value":351192.0,"total_display":"351,192.00","total_whole":"351,192","shares_owned_after":390557.0,"shares_owned_after_display":"390,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-08","scope":"insider"},{"id":9206331,"accession":"0000905148-16-001816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001816","line_url":"/filing/0000905148-16-001816#line-1","is_derivative":false,"issuer_cik":"0001665299","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001665299","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":802000.0,"shares_display":"802,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":8822000.0,"total_display":"8,822,000.00","total_whole":"8,822,000","shares_owned_after":912969.0,"shares_owned_after_display":"912,969","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-08-09","scope":"insider"},{"id":2964805,"accession":"0001140361-16-068155","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001140361-16-068155","line_url":"/filing/0001140361-16-068155","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":251553.0,"shares_display":"251,553","price_per_share":12.698016382233565,"price_display":"12.70","price_state":"stated","total_value":3194224.115,"total_display":"3,194,224.12","total_whole":"3,194,224","shares_owned_after":295399.0,"shares_owned_after_display":"295,399","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-01","scope":"insider","n_lines":6},{"id":2311134,"accession":"0000905148-16-001654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-16-001654","line_url":"/filing/0000905148-16-001654#line-1","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001665299","owner_name":"Traweek James W JR","owner_display_name":"Traweek James W JR","owner_url":"/insider/0001665299","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8035.0,"shares_display":"8,035","price_per_share":13.4199,"price_display":"13.42","price_state":"stated","total_value":107828.8965,"total_display":"107,828.90","total_whole":"107,829","shares_owned_after":370557.0,"shares_owned_after_display":"370,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":36,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Ten percent owner","n_filings":15,"first_seen":"2016-06-01","last_seen":"2019-11-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001665299","retrieved_at":"2026-08-23T10:57:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}